Founded by Vanessa Carter, a patient advocate since 2013 and survivor of a highly-resistant infection, The AMR Narrative was established to develop advocacy capacity, raise awareness, and promote community engagement in the fight against antimicrobial resistance (AMR).
As patients, consumers, pet owners, parents and caregivers, we play a crucial role in advocating for the responsible use of antimicrobial medicines. By protecting these medicines across human and animal health, the environment and food sectors, we can help ensure a more sustainable future—especially for those most vulnerable to untreatable infections.
Developing public and patient capacity around AMR to encourage participation and advocacy through ongoing programmes, mentorship, tools and resources.
Promoting public understanding and education for Antimicrobial Resistance through access to information and awareness raising.
Building a global community and providing a platform for patients and the public to engage in dialogues and other related opportunities related to AMR.
Microbes are part of nature and live all around us. Some of them even live harmoniously inside our bodies, but every now and again a bad one can cause an infection.
Some infections are resistant to the antimicrobial medicines designed to treat them. Microbes, also known as germs, include bacteria, fungi, viruses and parasites.
treat bacterial infections
treat fungal infections
treat viral infections
treat parasitic infections
Our Founder and Executive Director, Vanessa Carter, had the privilege of attending an exclusive pre-screening of AMR – Dying to Change the World on March 11, 2025. Hosted by the Fleming Initiative at the Curzon Theatre in Bloomsbury, London, the event showcased the compelling feature-length documentary on antimicrobial resistance (AMR) by filmmaker Alex Tweddle, made
On February 26th 2025, at the BEAM Alliance 9th AMR Conference in Basel, Switzerland, our Chair, Dr Francesca Chiara, participated in a panel discussion titled “Communicating on AMR, a Simple Matter of Wording?” She joined Kate Grailey (Fleming Initiative), Becky McCall (University College London) and Diane Shader Smith (Patient advocate and author) in exploring the nuances
On the 26th of September 2024, Prof. Renier Coetzee (Member of the Board of Trustees from The AMR Narrative) presented at an International Masterclass hosted by AMR Insights. The International Masterclass was designed for professionals who want to understand Antimicrobial Resistance (AMR) in a short time, and included: A comprehensive explanation of bacteria, antibiotics and resistance
Photo: 2016 My name is Hayley Bailey. I’m 46, and I live in Johannesburg, South Africa. I’m actually a relatively private person and didn’t have any intention of publicly sharing my story, however, I recently realised that speaking up could empower others facing similar challenges. My journey of “medical hell” began in 2007. I suffered
My name is Bhakti Chavan and I am an AMR patient survivor from India. As I neared the completion of my master’s degree in biotechnology at the age of 23 in 2017, I encountered a troubling development: gastrointestinal issues. Concerned by this, my father accompanied me to a gastroenterologist, who diagnosed irritable bowel syndrome. Thanks
https://www.youtube.com/watch?v=79QTsFAs0qo My name is Leticia Batista. I’m 28 years old and was born in Franca, a city in the state of São Paulo, Brazil. I graduated as a Physical Therapist in 2016 and moved to São Paulo in 2017 to work in a public hospital (Unified Health System – SUS). In February 2018, at 22
Advocacy plays a crucial role towards increasing awareness about the escalating threat of Antimicrobial Resistance (AMR) and the pressing need to take measures to prevent it. Advocacy also serves to educate policymakers, healthcare professionals, and the general public about the significance of using antibiotics and other antimicrobial medicines responsibly. Raising our voices and creating awareness may also help to promote changes in prescribing practices, improved infection prevention and control measures, and increased funding for research and development. Furthermore, advocacy can encourage discussions around reducing the misuse of antimicrobials in food, animals, and the environment which is a significant contributor to the problem of AMR.
Organisations we have partnered or shared our experience with:
Sign up to receive the latest news including upcoming events, programmes, AMR educational and advocacy resources and fundraising opportunities.
Sign up to receive the latest news including upcoming events, programmes, AMR educational and advocacy resources and fundraising opportunities.
Professor Esmita Charani is a pharmacist and researcher investigating how we use antibiotics in different cultural and social contexts. She works with teams in the UK, India, and South Africa to develop research programmes investigating all aspects of antimicrobial resistance in human populations with a focus in hospital settings.
She has experience in communicating her research with patients and the public through various media including animations, blogs, and educational videos.
